医学研究证明羟氯喹降低新型冠状病毒肺炎死亡率

2020年7月4日10:34:47医学研究证明羟氯喹降低新型冠状病毒肺炎死亡率已关闭评论 341 4858字阅读16分11秒
摘要

在这项研究中,也没有患者因使用该药物而遭受与心脏有关的问题。博士指出,如果患者在确诊为羟氯喹后尽早接受药物治疗,COVID-19更为有效。

7/3/2020

Trump Was Right Again~Imagine That!

特朗普又是对的~想象一下

Henry Ford Health Made New Discovery.

亨利·福特健康有了新发现


Officials with Henry Ford Health announced on Thursday that their study has shown that hydroxychloroquine"significantly"decreases the death rate of COVID-19 sufferers.They came to their conclusion after analyzing 2,541 patients who were confined in their hospital system from March 10 and May 2.They found that 13 percent of patients treated with hydroxychloroquine died while 26 percent of patients who did not receive the miracle drug died.

周四,Henry Ford Health 的官员宣布,他们的研究表明,羟氯喹可以"显著"降低COVID-19患者的死亡率。他们是在分析了从310日到52日期间被关在医院系统中的2541名患者后得出这一结论的。他们发现13%接受羟氯喹治疗的患者死亡,而26%没有接受这种神奇药物治疗的患者死亡。

"As doctors and scientists,we look to the data for insight,"said Steven Kalkanis,CEO of the Henry Ford Medical Group."And the data here is clear that there was a benefit to using the drug as a treatment for sick,hospitalized patients."

亨利·福特医疗集团的首席执行官史蒂文·卡尔卡尼斯说:"作为医生和科学家,我们从数据中寻找洞察力。""这里的数据很清楚,使用这种药物治疗住院病人是有好处的。"

There were also no heart-related problems that patients suffered from being treated with the drug in the study.Dr.Marcus Zervos noted that hydroxychloroquine is more effective when patients are treated with the drug early after their diagnosis with COVID-19.

在这项研究中,也没有患者因使用该药物而遭受与心脏有关的问题。博士指出,如果患者在确诊为羟氯喹后尽早接受药物治疗,COVID-19更为有效。

"We attribute our findings that differ from other studies to early treatment,and part of a combination of interventions that were done in supportive care of patients,including careful cardiac monitoring,"said Zervos,who works as division head of infectious disease for Henry Ford Health.Zervos conducted the study with epidemiologist Dr.Samia Arshad.

我们认为我们的研究结果与其他研究不同是因为早期治疗,以及对患者进行支持性治疗,包括仔细的心脏监测的综合干预措施的一部分,"Zervos 说,他是 Henry Ford Health 医疗传染病的部门主管。Zervos 与流行病学家 Samia Arshad 博士共同进行了这项研究。

"Our dosing also differed from other studies not showing a benefit of the drug,"he added."We also found that using steroids early in the infection associated with a reduction in mortality."

他补充说:"我们的剂量也不同于其他没有显示该药有益的研究。""我们还发现,在感染早期使用类固醇与降低死亡率有关。"

Zervos believes that the findings of this study could be crucial in stopping a potential second wave of COVID-19 infections from causing many more deaths.

认为这项研究的发现对于阻止潜在的第二波COVID-19感染导致更多的死亡是至关重要的。

Ever since President Trump suggested hydroxychloroquine as a remedy for COVID-19,there has been an institutional conspiracy to stop the treatment from being used to save the lives of the sick–as science and medicine have become extremely politicized.

自从特朗普总统建议用羟氯喹作为COVID-19的补救措施,就出现了一个制度性的阴谋来阻止这种治疗被用来拯救病人的生命-因为科学和医学已经变得极度政治化。

Last month,Big League Politics reported on how a study about hydroxychloroquine's fatal side effects was officially retracted after the data was shown to be erroneous:

上个月,大联盟政治报道了一项关于羟氯喹致命副作用的研究是如何在数据被证明是错误的后被正式撤销的:

The authors of a medical study published in medical journal The Lancet have been forced to retract their study claiming that hydroxychloroquine treatment had fatal side effects after several reports pointed out the faulty data.

发表在医学杂志《柳叶刀》上的一项医学研究的作者们被迫撤回了他们的研究,声称在一些报告指出错误的数据之后,羟氯喹治疗有致命的副作用。

The data was apparently used from a small Illinois firm called Surgisphere,owned by Dr.Sapan Desai.Desai had a sci-fi writer and a lewd model on staff for his company as the study was produced,and shockingly,it somehow produced inaccurate results.

这些数据显然来自伊利诺斯州一家名为 Surgisphere 的小公司,该公司由萨潘·德赛博士拥有。德赛在研究进行的时候,公司里有一个科幻小说作家和一个猥亵的模特,令人震惊的是,它竟然得出了不准确的结果。

The study was ultimately retracted after Dr.Mandeep R.Mehra,a Harvard Medical School professor who initially signed on to the study,tried to double check and verify the authenticity of the findings.Desai would not allow for the data to be re-analyzed,which eventually led to the retraction of the report.

哈佛医学院(Harvard Medical School)教授曼迪普·r·梅赫拉博士(dr.Mandeep r.Mehra)最初签署了这项研究,他试图再次核实研究结果的真实性,最终撤销了这项研究。德赛不允许对数据进行重新分析,这最终导致了报告的撤回。

"We launched an independent third-party peer review of Surgisphere with the consent of Sapan Desai to evaluate the origination of the database elements,to confirm the completeness of the database,and to replicate the analyses presented in the paper,"their statement said,according to the New York Times.

据《纽约时报》报道,他们在声明中表示:"在萨潘·德赛的同意下,我们启动了一项针对 Surgisphere 的第三方独立审查,以评估数据库元素的起源,确认数据库的完整性,并复制论文中的分析。"

"Our independent peer reviewers informed us that Surgisphere would not transfer the full dataset,client contracts,and the full ISO audit report to their servers for analysis as such transfer would violate client agreements and confidentiality requirements,"the authors added.

作者补充说:"我们的独立同行评审员告诉我们,Surgisphere 不会将完整的数据集、客户合同和完整的 ISO 审计报告转移到他们的服务器上进行分析,因为这样的转移将违反客户协议和保密要求。"

The disgraced World Health Organization(WHO)reportedly stopped research into hydroxychloroquine as treatment for COVID-19 because of the findings in this dubious report,adding to the laundry list of public health failures the globalist body has been responsible for throughout the coronavirus pandemic.

据报道,颜面尽失的世界卫生组织停止了对羟氯喹的研究,因为这份可疑的报告中的发现,这个全球主义机构在整个冠状病毒大流行期间一直在为公共卫生失败负责。

President Donald Trump has been vindicated for suggesting hydroxychloroquine as a COVID-19 cure.His bold leadership has saved lives while many medical professionals have kept this lifesaving drug out of the hands of the sick.

美国总统唐纳德·特朗普建议将羟氯喹视为COVID-19解药,这一点已被证明是正确的。他的大胆领导拯救了许多生命,而许多医学专业人士却不让这种拯救生命的药物进入病人的手中。

来源:

https://c-vine.com/blog/2020/07/03/medical-study-proves-that-hydroxychloroquine-lowers-covid-19-death-rate/

  • 本文由 发表于 2020年7月4日10:34:47
  • 除非特殊声明,本站文章均来自网络,转载请务必保留本文链接